Search - tctmd.com

Displaying 161 - 180 of 203

Sort: Relevancy | Date

News Opinion CV Team Dispatch

September 2020 News Roundup

L.A. McKeown

September 01, 2020

News Opinion CV Team Dispatch

August 2020 News Roundup

L.A. McKeown

August 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

July 2020 News Roundup

L.A. McKeown

July 01, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

News Daily News

Too Many HF Trial Results Underreported or Never Published

L.A. McKeown

June 23, 2020

News Daily News

June 2020 News Roundup

L.A. McKeown

June 01, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Opinion CV Team Dispatch

May 2020 News Roundup

L.A. McKeown

May 06, 2020

News Features

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

Shelley Wood

April 21, 2020

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

News Opinion Off Script

COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose?

Asif Qasim, MB BChir, PhD

March 06, 2020

News Daily News

First ESC Meeting of 2020 Canceled Due to Novel Coronavirus

Todd Neale

March 04, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Daily News

Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation

Todd Neale

February 04, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Features

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Caitlin E. Cox

December 17, 2019

Advertisement

September 2020 News Roundup

August 2020 News Roundup

TCTMD’s Top 10 Most Popular Stories for July 2020

July 2020 News Roundup

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

Too Many HF Trial Results Underreported or Never Published

June 2020 News Roundup

Cardiology After COVID-19: Physicians Predict Lasting Change

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

May 2020 News Roundup

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

ACC, EHRA Cancel 2020 Meetings Over COVID-19

COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose?

First ESC Meeting of 2020 Canceled Due to Novel Coronavirus

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content